[Ophthalmological symptomatology, therapy and prognosis of Fuch's and Lyell's syndromes].
D000328:Adult; D001379:Azathioprine / Q000008:administration & dosage; D001835:Body Weight; D003318:Corneal Opacity / Q000175:diagnosis* / Q000188:drug therapy; D003348:Cortisone / Q000009:adverse effects / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004774:Entropion / Q000209:etiology; D004892:Erythema Multiforme / Q000150:complications; D005076:Exanthema / Q000150:complications; D005260:Female; D006801:Humans; D007249:Inflammation / Q000150:complications; D007637:Keratoconjunctivitis / Q000175:diagnosis* / Q000188:drug therapy; D007765:Lacrimal Apparatus; D008297:Male; D008875:Middle Aged; D009262:Nails; D011379:Prognosis; D013262:Stevens-Johnson Syndrome / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D013280:Stomatitis / Q000175:diagnosis* / Q000188:drug therapy
D001379:Azathioprine; D003348:Cortisone
Zur ophthalmologischen Symptomatologie, Therapie und Prognose des Fuchs- und Lyell-Syndroms.